ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 761817 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 761817; 2) Community: the network communities that were significantly associated with the response to NSC 761817; 3) Molecule: the relationships between components within communities and NSC 761817; 4) MDR: the compounds that were significantly associated with the NSC 761817.

NSC Compound Enrichment Correlation
NSC 269720 Androstan-17-one, 3-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (3.alpha.,5.alpha.)- 0.0403978426119736 0.0093111514
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.0403978426119736 0.30943891
NSC 300289 Pinafide 0.0403978426119736 0.018702667
NSC 328410 Camptothecin Derivative 0.0403978426119736 0.14513447
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0403978426119736 0.28385441
NSC 354974 Acetamide, N-(5,6,7,9-tetrahydro-2,3-dihydroxy-1,10-dimethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- 0.0403978426119736 0.32856449
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.0403978426119736 0.057135108
NSC 371777 Null 0.0403978426119736 0.15465135
NSC 42972 Null 0.0403978426119736 0.29895704
NSC 55236 Null 0.0403978426119736 0.19060051
Total:94  Current:81    [First] [Prev] [Next] [Last]